Advancing Depression Treatment: Real-World Applications of Glutamate Pathway Targeting
This article explores the transformative impact of Spravato (esketamine), a nasal spray targeting the glutamate system, in treating severe depression. Highlighting a case study, it underscores rapid symptom relief, the importance of individualized dosing, and sustained improvements, while addressing challenges like insurance access and advocating for personalized care.